Dulaglutide (Trulicity) – A Weekly GLP-1 Agonist for Type 2 Diabetes

 Dulaglutide (Trulicity) is a once-weekly GLP-1 receptor agonist designed to enhance blood sugar control in type 2 diabetes. Its convenience and effectiveness have made it a popular choice among patients seeking long-term glucose management.

How Dulaglutide Works

Dulaglutide mimics natural GLP-1, a hormone that regulates insulin secretion and glucose metabolism. It:

• Increases Insulin Production – Stimulates insulin release when blood sugar is high.
• Suppresses Glucagon Secretion – Prevents excessive glucose production by the liver.
• Slows Gastric Emptying – Delays digestion, leading to steadier blood sugar levels.

Key Benefits

• Convenient Weekly Dosing – Eliminates the need for daily injections.
• Effective A1C Reduction – Lowers average blood sugar levels over time.
• Supports Weight Loss – Helps reduce appetite and food intake.

Potential Side Effects

Nausea, diarrhea, and digestive discomfort are common early on. Rare risks include pancreatitis and thyroid tumor concerns, requiring further study.

Dulaglutide remains a leading GLP-1 therapy, offering convenience, efficacy, and weight management benefits.